MOLDTKPAC: Q2 growth accelerated, led by pharma and Food & FMCG, with new launches ahead

What happened

Mold Tek Packaging's Q2 FY27 revenue rose 30.73%, EBITDA rose 29.80% and net profit rose 36.06% from a year earlier. Pharma and Food & FMCG led volume growth, and the company expects new product launches and capacity work to support its outlook.

Confirmed

Global impact / market context

Faster revenue than EBITDA growth suggests costs rose alongside sales, though net profit grew fastest, so profit per sale improved. Rising sales volume means more packaging units sold, which is how a packaging maker turns demand into revenue, cash and capacity planning.

Analyst inference

Pharma and Food & FMCG customers leading volume growth points to steady demand from everyday products rather than one customer group. New launches and capacity spending signal management expects growth to continue, which affects future revenue, costs and cash available for investment.

Analyst inference

What to watch

1. Whether new product launches add sales and whether capacity initiatives start running as planned, since these underpin the stated outlook for the business. Confirmed
2. Investors could compare future quarters to see if pharma and Food & FMCG keep leading volume growth or if demand shifts to other customer groups. Proposed
3. Watch whether revenue growth keeps outpacing profit growth or reverses, because that gap shows whether costs are rising faster than sales. Analyst inference

Evidence

• Original source link unavailable